Filing Details
- Accession Number:
- 0001093557-15-000327
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-21 18:15:20
- Reporting Period:
- 2015-09-18
- Filing Date:
- 2015-09-21
- Accepted Time:
- 2015-09-21 18:15:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1408993 | Jess Roper | 6340 Sequence Drive San Diego CA 92121 | Svp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-09-18 | 1,000 | $101.35 | 99,424 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-09-18 | 6,000 | $9.80 | 105,424 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-09-18 | 6,000 | $101.20 | 99,424 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2015-09-18 | 6,000 | $101.20 | 6,000 | $9.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,990 | 2011-03-12 | 2020-03-12 | No | 4 | M | Direct |
Footnotes
- On November 17, 2014, Mr. Roper adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Roper. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- This transaction was executed in multiple trades at prices ranging from $100.01 to $102.66. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- Included in this number are 60,000 unvested restricted stock units, 40,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 15,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017 and 5,000 of which were granted on March 11, 2013 and shall vest through March 11, 2016.
- This transaction was executed in multiple trades at prices ranging from $99.93 to $102.66. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Billionaire Hedge Funds
